RxDoctor Payments Data

Fred Cohen

Internal Medicine · San Francisco, CANPI 1750445581

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $916,798 of the $928,962 with a category attached, or 98.7%. Urogen Pharma, Inc. accounts for 70.8% of it on its own, with 1 other manufacturer making up the rest. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$928,962in general payments, 2019–2025

Across 32 payments — averaging $29,030 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Urogen Pharma, Inc.$658K
  • Tandem Diabetes Care, Inc.$271K

What the payments were for

  • Speaking & faculty fees$916,79899%
  • Travel & lodging$11,1141%
  • Food & beverage$1,0500%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Urogen Pharma, Inc.30$657,884
Tandem Diabetes Care, Inc.2$271,078

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$928,962 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in San Francisco

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →